• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery.

作者信息

Ghirardi Valentina, Trozzi Rita, Scambia Giovanni, Fagotti Anna

机构信息

Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy.

Gynecologic Oncology, Catholic University, Roma, Italy.

出版信息

Ann Surg Oncol. 2024 Jul;31(7):4580-4581. doi: 10.1245/s10434-024-15124-z. Epub 2024 Mar 6.

DOI:10.1245/s10434-024-15124-z
PMID:38446331
Abstract
摘要

相似文献

1
ASO Author Reflections: Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery.ASO作者反思：在间歇性减瘤手术时扩大热灌注化疗在卵巢癌中的应用
Ann Surg Oncol. 2024 Jul;31(7):4580-4581. doi: 10.1245/s10434-024-15124-z. Epub 2024 Mar 6.
2
ASO Author Reflections: One Size Does Not Fit All-Enhanced Recovery After Surgery in CRS-HIPEC.ASO作者反思：一刀切并不适用于所有情况——结直肠癌合并腹腔热灌注化疗术后的加速康复。
Ann Surg Oncol. 2024 Aug;31(8):5400-5401. doi: 10.1245/s10434-024-15427-1. Epub 2024 May 24.
3
ASO Author Reflections: Integrating Multimodal Pain Management Protocols into ERAS for Patients Undergoing CRS-HIPEC.ASO作者反思：将多模式疼痛管理方案整合到接受CRS-HIPEC治疗的患者的加速康复外科中。
Ann Surg Oncol. 2024 Jul;31(7):4741-4742. doi: 10.1245/s10434-024-15178-z. Epub 2024 Mar 14.
4
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer.晚期上皮性卵巢癌患者行间隔减瘤术联合或不联合腹腔热灌注化疗后吻合口漏的发生情况。
Gynecol Oncol. 2021 Sep;162(3):645-651. doi: 10.1016/j.ygyno.2021.06.034. Epub 2021 Jul 9.
5
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.腹腔内热灌注化疗在晚期上皮性卵巢癌间隔肿瘤细胞减灭术中的应用：单中心真实世界经验。
Cancer. 2020 Dec 15;126(24):5256-5262. doi: 10.1002/cncr.33167. Epub 2020 Sep 15.
6
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.在 III 期原发性卵巢癌中，采用新辅助化疗 6 个周期，随后进行细胞减灭术和腹腔热灌注化疗（HIPEC）的新治疗方案。
Surg Oncol. 2021 Jun;37:101523. doi: 10.1016/j.suronc.2021.101523. Epub 2021 Jan 31.
7
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer.评估微创与剖腹手术相比在晚期上皮性卵巢癌间歇性肿瘤细胞减灭术联合腹腔热灌注化疗中的可行性和围手术期结局。
Gynecol Oncol. 2021 Jan;160(1):45-50. doi: 10.1016/j.ygyno.2020.09.052. Epub 2020 Oct 14.
8
Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis.细胞减灭术联合腹腔热灌注化疗治疗原发性晚期和铂敏感复发性上皮性卵巢癌的预后价值和不良事件：系统评价和荟萃分析。
Int J Hyperthermia. 2023;40(1):2165729. doi: 10.1080/02656736.2023.2165729.
9
A Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy in Primary Advanced Ovarian Cancer: The First Reported Pilot Experience from Saudi Arabia.原发性晚期卵巢癌的细胞减灭术加腹腔内热灌注化疗：来自沙特阿拉伯的首次报道的初步经验。
Gulf J Oncolog. 2020 Sep;1(34):19-25.
10
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.腹腔内热灌注化疗治疗卵巢癌。
Ann Surg Oncol. 2023 Sep;30(9):5597-5609. doi: 10.1245/s10434-023-13757-0. Epub 2023 Jun 26.

本文引用的文献

1
Author's reply to correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Mukurdipi Ray et al.作者对Mukurdipi Ray等人关于“在中间性肿瘤细胞减灭术中将腹腔热灌注化疗扩展应用于FIGO IV期卵巢癌及新辅助化疗6周期后的应用：一项前瞻性分析及围手术期和肿瘤学结局”的通信的回复
Ann Surg Oncol. 2024 Aug;31(8):5121. doi: 10.1245/s10434-024-15503-6. Epub 2024 May 30.
2
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.根据HRD/BRCA野生型基因组特征，热灌注化疗（HIPEC）在III期卵巢癌中的疗效：III期OVHIPEC试验结果
Int J Cancer. 2022 Oct 15;151(8):1394-1404. doi: 10.1002/ijc.34124. Epub 2022 Jun 4.
3
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.原发性细胞减灭术联合或不联合腹腔热灌注化疗（HIPEC）治疗国际妇产科联盟（FIGO）分期 III 期上皮性卵巢癌：OVHIPEC-2，一项 III 期随机临床试验。
Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23.